Radboud
Welcome,         Profile    Billing    Logout  
 4 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Herpen, Carla van
LUPSA, NCT04291300: Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients

Completed
2
12
Europe
Lutetium-177-PSMA-I&T, Lutetium-177 Prostate Specific Membrane Antigen
Radboud University Medical Center, Dutch Cancer Society
Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma
02/23
02/23
OpcemISA, NCT03669718 / 2018-000789-13: A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

Active, not recruiting
2
194
Europe, US, RoW
ISA101b, Cemiplimab, Placebo
ISA Pharmaceuticals, Regeneron Pharmaceuticals
Squamous Cell Carcinoma of the Oropharynx, HPV16 Positive
09/24
06/25
DUCT, NCT05513365: Phase II Dutasteride in Combination With CAB vs CAB in SDC

Recruiting
2
26
Europe
Goserelin 10.8 mg, Zoladex, Bicalutamide 50 mg, Casodex, Dutasteride 0.5 mg, Avodart
Radboud University Medical Center, ZonMw: The Netherlands Organisation for Health Research and Development
Salivary Duct Carcinoma
09/25
09/27
COMMENCE, NCT02054442 / 2013-002886-20: A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck

Active, not recruiting
1/2
52
Europe
Cetuximab, Erbitux, L01XC06, Methotrexate, EMTHEXATE, L01BA01
Radboud University Medical Center, Merck Serono International SA, Leiden University Medical Center, Academisch Ziekenhuis Maastricht, Erasmus Medical Center, Medisch Spectrum Twente, Medical Center Haaglanden, Elisabeth-TweeSteden Ziekenhuis, Medical Centre Leeuwarden
Squamous Cell Carcinoma of the Head and Neck
12/21
12/22
MCLA-158-CL01, NCT03526835: A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Recruiting
1/2
360
Europe, US
MCLA-158, petosemtamab, MCLA-158 +Pembrolizumab
Merus N.V., Chiltern International Inc., Q2 Solutions, Oncology Therapeutic Development (OTD), 4Clinics
Advanced/Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Gastroesophageal-junction Cancer, NSCLC, HNSCC, Head and Neck Squamous Cell Carcinoma
06/24
06/25
DF1001-001, NCT04143711: Study of DF1001 in Patients With Advanced Solid Tumors

Recruiting
1/2
378
Europe, US
DF1001, Nivolumab, Nab paclitaxel, Sacituzumab Govitecan-hziy
Dragonfly Therapeutics
Solid Tumor, Adult
10/26
12/26
NCT05752552: Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours

Recruiting
1
25
Europe
DO-2
DeuterOncology
Adult Solid Tumor, Advanced Solid Tumor, Refractory Tumor, Non-small Cell Lung Cancer, Non-small Cell Carcinoma, Lung Cancer, Hereditary Renal Papillary Cancer
10/24
04/25
BYON3521.001, NCT05323045: A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate BYON3521

Active, not recruiting
1
31
Europe
BYON3521
Byondis B.V.
Solid Tumor
07/24
07/24
ADT-SCAN, NCT04214353: PSMA-PET Imaging Before and After ADT in Advanced SDC Patients

Recruiting
N/A
14
Europe
68Ga-PSMA-PET/CT, 18FDG-PET/CT
Radboud University Medical Center, Dutch Cancer Society
Salivary Gland Cancer, Salivary Duct Carcinoma
05/23
09/23
Geffen, Geert-Jan van
CT2Trachospray, NCT05478122: Soft Mist Spray Device for Airway Anaesthesia During Awake Videolaryngoscopy

Completed
N/A
20
Europe
Trachospray for awake videolaryngoscopy
Radboud University Medical Center
Airway, Anesthesia, Local
02/23
02/23
ON-SCENE, NCT04620070: Initiation of Extracorporeal CardioPulmonary Resuscitation During Refractory Out-of-Hospital Cardiac Arrest

Recruiting
N/A
390
Europe
ECPR
Erasmus Medical Center, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Radboud University Medical Center, University Medical Center Groningen, Leiden University Medical Center, Haga Hospital, St. Antonius Hospital, Isala, Catharina Ziekenhuis Eindhoven, Amphia ziekenhuis
Extracorporeal Membrane Oxygenation, Cardiac Arrest
07/25
07/26

Download Options